New publication from @RenBioNYC on ultra long-lasting GLP-1 molecules in vivo - one year of sustained weight loss from one injection. https://t.co/GhIwaXgFPk
People miss how uncertain major biotech breakthroughs look in real time. As my @Curie_Bio colleague Greg Carven @MadMabScientist discusses, Keytruda came surprisingly close to never happening. Great behind-the-scenes look at drug development of a major blockbuster oncology drug.
Keytruda transformed cancer care and made Merck more money than any drug in history. It was also discovered by accident, and nearly out-licensed in 2010 for pocket change.
New Approved + exclusive interviews with the inventors and the Merck CMO who ran development:
If you're a biotech founder considering applying next year, I cannot recommend it enough. Your company (and you) will be stronger because of it. (4/4) #Biotech#Entrepreneurship
https://t.co/Bqk9qbaabX
Having gone through @EFrontierLabs as a founder several years ago, and now returning as a mentor, I’ve seen both sides of what makes this program work. That balance is hard to get right, and it shows the caliber of companies coming out of the program. (1/4)
Grateful to be part of this incredible community of founders and entrepreneurs, especially to @ArthurKlausner for introducing me to the program in the first place! (3/4)
I'm excited to share that I'm taking on a new position with our investors, https://t.co/ZbW9iov7R2. While continuing with my responsibilities at Astoria Biologica, I will also be helping Curie run more companies in their portfolio as a CXO in Residence! https://t.co/cI9QcwWAzq
Thank you @LambdaLegal for fighting for equality on behalf of the LGBTQ+ community & people living with HIV for the past 50 years. Your passion and commitment was evident at the event. Thank you for your pioneering work!
Full house here in Milan for the annual @ECTRIMS - ACTRIMS meeting. The Day 1 buzz is palpable. Excited to learn the latest in MS research & development. Even more excited to meet colleagues & collaborators in person after months of Zoom meetings! #MSMilan2023
What a beautiful example of basic research leading to translational science leading to profound public health impact. This is just the beginning of the potential for nucleic acid-based therapeutic technologies!
BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
Thanks OUTbioGNY for organizing a fantastic evening volunteering & serving ice cream to the @HetrickMartin youth. What an honor to serve this innovative organization providing essential services to LGBTQIA+ youth, sore ice-cream-scooping-arm and all!
Great article on the tremendous need for non-viral nucleic acid delivery technologies like the one @RenBioNYC is creating! #NYCBiotech
https://t.co/NBeXVULDQ1
Back in Boston to learn about the latest breakthroughs in neurology and to meet new colleagues in person for the first time at the American Academy of Neurology Annual Meeting. Let's go! #AANAM#AANAM2023@AANmember
Here we go!
I have some personal business news here and it is thrilling. After lengthy transatlantic talks, The Financial Times has acquired a majority interest in Endpoints News. This is transformational for us. We’re incredibly proud to be a new part of this media enterprise
Great article about one of NYC's biotech entrepreneurs. I first learned about @RocketPharma when we were neighbors at the Alexandria Center for Life Sciences and they hosted their inaugural rare disease day. It was an inspirational day. #nycbiotech
https://t.co/aY5JLPX9gS
Excited to announce my new role as Founding Team Member, Head of Ops & Strategy at Astoria Biologica, a new biotech developing novel therapies for MS and backed by the new VC & therapeutics accelerator https://t.co/ZbW9iovFGA. Let's goooo!
https://t.co/hgdaj5q4X7
@Novartis opening a new 15K SF office in NYC near Bryant Park. Another great example of the growing #nycbiotech ecosystem. When your team needs recs for the best breakfast BEC or lunchtime halal cart in your new neighborhood, we've got you covered!
https://t.co/mtTJD2quZF
@ShafferBiotech Hi @ShafferBiotech. I spent years working on HIV antibody development programs and have folks in my network that ran NHP Ab PK studies (mainly rhesus macaques, some cynos). If this would be helpful, send me a DM with what you are looking for and I can connect you.